medigraphic.com
ISSN 1561-3054 (Electronic)

2019, Number 1

<< Back Next >>

Rev Cubana Med Trop 2019; 71 (1)

Laboratory surveillance of dengue fever and other arboviruses in Cuba, 1970- 2017

Guzmán MG, Vázquez S, Álvarez M, Pelegrino JL, Ruiz AD, Martínez PA, Pupo M, Morier LVL, Peláez O, Valdivia I, Llop A

Language: Spanish
References: 55
Page: 1-31
PDF size: 322.91 Kb.


ABSTRACT

Arboviruses are one of the leading causes of health emergencies due to their morbidity and mortality and the sanitary stress they bring about. Cuba has not been free from risk, and the response first to dengue fever and then to other arboviruses has been and still is a priority for the country's top authorities. Laboratory surveillance of dengue fever was implemented in the 1970s, though its aims and strategies have evolved in keeping with the national and regional epidemiological situation, and the available diagnostic technology. Four stages stand out in the development of dengue laboratory surveillance. The present paper summarizes the strategies developed for laboratory surveillance of dengue fever and other arboviruses in the period 1970-2017. A description is also provided of the role played by Pedro Kourí Tropical Medicine Institute (IPK) as a national reference laboratory.


REFERENCES

  1. Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016;18(2):16055.

  2. Patterson J, Sammon M, Garg M. Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World. West J Emerg Med. 2016 Nov;17(6):671-9.

  3. PAHO. Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control.Scientific publication. Pan American Health Organization Scientific advisory committee on dengue Third meeting Mayo. 1994;548.

  4. Guzman MG. Thirty years after the Cuban hemorrhagic dengue epidemic of 1981. MEDICC review. 2012;14(2):46-51.

  5. OPS. Número de casos reportados de Chikungunya en países o territorios de las Américas, 2014 Semana Epidemiológica 2014 29 diciembre;52.

  6. PAHO/WHO. Zika cases and congenital syndrome asscoaiated with Zika virus reported by countries and territories in the Americas, 2015-2017. Cumulative cases. [cited 2017 Oct 24]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=12390:z ika-cumulative-cases&Itemid=42090&lang=en

  7. Ministério da Saúde Secretaria de Vigilância em Saúde. COES – Febre Amarela . Centro de Operacoes de emergencias em Saude Publica sobre Febre Amarela. Informe No. 43/2017 [cited 2017 Oct 24]. Available from: http://portalarquivos.saude.gov.br/images/pdf/2017/junho/02/COES-FEBREAMARELA-- INFORME-43---Atualiza----o-em-31maio2017.pdf

  8. Mas Lago P. Dengue fever in Cuba in 1977: some laboratory aspects. PAHO Scientific Publication. 1979;375:40-3.

  9. Kouri GP, Guzman MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bulletin of the World Health Organization. 1989;67(4):375-80.

  10. Valdes L, Guzman MG, Kouri G, Delgado J, Carbonell I, Cabrera MV, et al. La epidemiología del dengue y del dengue hemorrágico en Santiago de Cuba, 1997. Revista Panamericana de Salud Pública. 1999;6(1):16-25.

  11. Guzman MG, Pelaez O, Kouri G, Quintana I, Vazquez S, Penton M, et al. Caracterización final y lecciones de la epidemia de dengue 3 en Cuba, 2001-2002. . Revista Panamericana de Salud Pública. 2006 Apr;19(4):282-9.

  12. Pelaez O, Guzman MG, Kouri G, Perez R, San Martin JL, Vazquez S, et al. Dengue 3 epidemic, Havana, 2001. Emerging Infectious Diseases. 2004 Apr;10(4):719-22.

  13. Guzman MG, Kouri G. Dengue: an update. The Lancet Infectious Diseases. 2002 Jan;2(1):33-42.

  14. OPS. Brote de dengue en Cuba, 2006. EER Noticias: enfermedades infecciosas emergentes y reemergentes, Región de las Américas. 2006;3(24).

  15. Vazquez S, Bravo JR, Perez AB, Guzman MG. ELISA de Inhibición. Su utilidad para clasificar un caso de dengue. Rev Cuba Med Trop. 1997;49(2):108-12.

  16. Vazquez S, Saenz E, Huelva G, Gonzalez A, Kouri G, Guzman MG. Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro. Revista Panamericana de Salud Pública. 1998;3(3):174-8.

  17. Guzman MG, Buchy P, Enria D, Vazquez S. Laboratory diagnosis of dengue. In: Gubler DJ, Ooi EE, Vasudevan S, Farrar J, editors. Dengue and Dengue Hemorrhagic Fever. Wallingford, UK: CAB International; 2014.

  18. Vazquez S, Valdivia I, Sanchez A, Calzada N, Guzman MG. Evaluación del sistema dignóstico UMELISA Dengue IgM PLUS. Archivos Venezolanos de Medicina Tropical 2007;5(1):4-18.

  19. MINSAP. Guías cubanas para la atención integral a pacientes con dengue. La Habana: Editorial Ciencias Médicas; 2012.

  20. Cantelar N, Albert L, Balbis E. Circulación de dengue en Cuba, 1978-1979. Rev Cuba Med Trop. 1981;33(1):72-8.

  21. Morier Diaz L, Aleman Miranda MR, Castillo Alvarez A, Perez Forcada V. Preliminary study of AP-64 cell line (Aedes pseudoscutellaris) for dengue-1 and -2 virus multiplication. Rev Cuba Med Trop. 1991;43(3):156-61.

  22. Kouri G, Guzman MG, Valdes L, Carbonel I, del Rosario D, Vazquez S, et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerging Infectious Diseases. 1998 Jan-Mar;4(1):89-92.

  23. Guzman MG, Valdes L, Pelaez O. Dengue en Cuba. In: Guzman MG, editor. Dengue. La Habana, Cuba. 2014. p. 62-89.

  24. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. Journal of Clinical Microbiology. 1992 Mar;30(3):545-51.

  25. Rodriguez-Roche R, Alvarez M, Guzman MG, Morier L, Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. Journal of Clinical Microbiology. 2000 Sep;38(9):3508-10.

  26. Pupo M, Guzmán MG, Fernández R, Llop A, Dickinson FO, Pérez D, et al. West Nile Virus infection in humans and horses, Cuba. Emerging infectious diseases. 2006;12(6):1022-4.

  27. Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Neglected Tropical Diseases. 2013;7(7):e2311.

  28. Panning M, Hess M, Fischer W, Grywna K, Pfeffer M, Drosten C. Performance of the RealStar Chikungunya virus real-time reverse transcription-PCR kit. Journal of Clinical Microbiology. 2009;47(9):3014-6.

  29. Johnson BW, Russell BJ, Goodman CH. Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays. J Infect Dis. 2016 Dec 15;214(Suppl 5):S471-s4.

  30. Lanciotti RS, Lambert AJ, Holodniy M, Saavedra S, Signor LdC. Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerging Infectious Diseases. 2016;22(5):933-5.

  31. Trioplex Real-time RT-PCR Assay Centers for Disease Control and Prevention [cited 2017 Oct 24]. Available from: http://www.fda.gov/downloads/medicaldevices/safety/emergencysituations/ucm4915 92.pdf

  32. Grobbelaar AA, Weyer J, Moolla N, Jansen van Vuren P, Moises F, Paweska JT. Resurgence of Yellow Fever in Angola, 2015-2016. Emerging Infectious Diseases. 2016 Oct;22(10):1854-5.

  33. Khan AW, Nasim Z, Zahir F, Khan MA, Ali A, Ali S, et al. Resurgence of yellow fever in Brazil: Overview and possible control options. Acta Microbiologica et Immunologica Hungarica. 2017;64(3):353-6.

  34. Mantel N, Aguirre M, Gulia S, Girerd-Chambaz Y, Colombani S, Moste C, et al. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines. Journal of Virological Methods. 2008 Jul;151(1):40-6.

  35. Emergencies preparedness, response. Yellow fever – Angola. Disease Outbreak News. 2016 June 14 [cited 2017 Oct 24]. Available from: http://www.who.int/csr/don/14-june-2016-yellow-fever-angola/es

  36. Valdivia I, Palenzuela A, Herrera R, Silva C, Feal S, Alcántara D, et al. UMELISA Dengue IgM PLUS: Nuevo ensayo para la detección de IgM anti-Dengue por SUMA. Rev Latinoamericana de Microbiología. 2002;44(4).

  37. Alvarez Vera M, Gonzalez Rodriguez A, Diaz Morejon D, Morier Diaz L, Guzman Tirado MG. Normalización de la técnica de neutralización por placas en las células Vero para los virus del dengue. Revista Cuba Med Trop. 2010 May- Aug;62(2):138-45.

  38. Rosario D, Alvarez M, Diaz J, Contreras R, Rodriguez R, Vazquez S, et al. Reacción en cadena de la polimerasa para la detección rapida y determinación del serotipo de virus del dengue en muestras clínicas. Revista Panamericana de Salud Pública 1998;4(1):1-5.

  39. Morier L, Camacho DE, Guzman MG, Alvarez M, Rodriguez R, Comach G. Comportamiento biológico de 3 cepas del virus dengue-2 en 2 líneas celulares de mosquitos Rev Cub Med Trop. 2000;52(3):215-9.

  40. Vazquez S, Cabezas S, Perez AB, Pupo M, Ruiz D, Calzada N, et al. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. International journal of Infectious Diseases. 2007 May;11(3):256-62.

  41. Ruiz D, Vazquez S, Rios HC, Calzada N, Guzman MG. Immunoglobulin A Antibody Responses in Patients with Primary or Secondary Dengue Infections. Open Access Library Journal. 2016;3:e3212.

  42. Vazquez S, Ruiz D, Barrero R, Ramirez R, Calzada N, del Rosario Pena B, et al. Kinetics of dengue virus NS1 protein in dengue 4-confirmed adult patients. Diagnostic Microbiology and Infectious Disease. 2010 Sep;68(1):46-9.

  43. Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, Kroeger A, et al. Multi-country evaluation of the sensitivity and specificity of two commerciallyavailable NS1 ELISA assays for dengue diagnosis. PLoS Neglected Tropical Diseases. 2010;4(8):1-10.

  44. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerging Infectious Diseases. 2009 Mar;15(3):436-40.

  45. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody. PLoS Neglected Tropical Diseases. 2014;8(10):1-11.

  46. Vazquez S, Fernandez R, Llorente C. Utilidad de sangre almacenada en papel de filtro para estudios serológicos por ELISA de Inhibición. Revista do Instituto de Medicina Tropical de Sao Paulo. 1991 Jul-Aug;33(4):309-11.

  47. Prado I, Rosario D, Bernardo L, Alvarez M, Rodriguez R, Vazquez S, et al. PCR detection of dengue virus using dried whole blood spotted on filter paper. Journal of Virological Methods. 2005 Apr;125(1):75-81.

  48. Pelegrino JL, Arteaga E, Rodriguez AJ, Gonzalez E, Frontela MD, Guzman MG. Normalización de técnicas inmunohistoquímicas para la detección de antígenos del virus dengue en tejidos embebidos en parafina. Rev Cub Med Trop. 1997;49(2):100-7.

  49. Guzman MG, Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008 Jun;102(6):522-3.

  50. Alvarez M, Rodriguez-Roche R, Bernardo L, Vazquez S, Morier L, Gonzalez D, et al. Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. American Journal of Tropical Medicine and Hygiene. 2006 Dec;75(6):1113-7.

  51. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. American Journal of Epidemiology. 2000 Nov 1;152(9):793-9.

  52. Rodriguez-Roche R, Sanchez L, Burgher Y, Rosario D, Alvarez M, Kouri G, et al. Virus role during intraepidemic increase in dengue disease severity. Vector Borne and Zoonotic Diseases. 2011 Jun;11(6):675-81.

  53. Limonta D, Falcon V, Torres G, Capo V, Menendez I, Rosario D, et al. Dengue virus identification by transmission electron microscopy and molecular methods in fatal dengue hemorrhagic fever. Infection. 2012 Dec;40(6):689-94.

  54. RELDA - Antecedentes. Cronología de la Red de Laboratorios de Diagnóstico de Arbovirus de las Américas (RELDA) [cited 2017 Oct 24]. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=12904% 3Arelda-background-information&catid=8990%3Arelda-network- &Itemid=42243&lang=es

  55. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504-7.




2020     |     www.medigraphic.com